Predictive models in colorectal liver metastases - Can we personalize treatment and outcome?

Digestive Surgery

Volumn 25, Issue 6, 2009, Pages 406-412

  Welsh, Fenella K S ^a   Tekkis, Paris P ^b   John, Timothy G ^a   Rees, Myrddin ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Hepatectomy; Metastatic colorectal cancer; Risk prediction; Survival

Indexed keywords

CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; CONSENSUS; HUMAN; LIVER METASTASIS; LIVER RESECTION; MEDICAL LITERATURE; ONCOLOGY; OUTCOME ASSESSMENT; PROGNOSIS; SURVIVAL TIME; TREATMENT PLANNING; VALIDATION STUDY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 60149109148     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184731     Document Type: Conference Paper

References (33)

1. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J: Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410.
2. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal cancer: impact of surgical resection on the natural history. Br J Surg 1990;77:1241-1246.
3. Sugarbaker PH: Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990;174:621-626.
4. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 1999;230:309-318.
5. Rees M, Plant G, Bygrave S: Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997;84:1136-1140.
6. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
7. Adam R, Huguet E, Azoulay D, et al: Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 2003;12:211-220.
8. Abdalla EK, Vauthey JN, Ellis LM, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-825.
9. Zorzi D, Laurent A, Pawlik TM, et al: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274-286.
10. Nordlinger B, Sorbye H, Glimelius B, et al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371:1007-1016.
11. Adam R, Delvart V, Pascal G, et al: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-657.
12. Ercolani G, Grazi GL, Ravaioli M, et al: Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs. number or location, on long-term survival. Arch Surg 2002;137:1187-1192.
13. Iwatsuki S, Dvorchik I, Madariaga JR, et al: Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999;189:291-299.
14. Schindl M, Wigmore SJ, Currie EJ, et al: Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 2005;140:183-189.
15. Scheele J, Altendorf-Hofmann A, Grube T, et al: Resection of colorectal liver metastases: what prognostic factors determine patient selection? Chirurg 2001;72:547-560.
16. Kato T, Yasui K, Hirai T, et al: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003;46:S22-S31.
17. Simmonds PC, Primrose JN, Colquitt JL, et al: Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006;94:982-999.
18. Poston GJ, Adam R, Alberts S, et al: Onco-Surge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 2005;23:7125-7134.
19. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, et al: Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 2000;19:1059-1079.
20. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
21. Efron B, Tibshirani R: An Introduction to the Bootstrap. New York, Chapman & Hall, 1993.
22. Nordlinger B, Guiguet M, Vaillant JC, et al: Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1,568 patients. Association Française de Chirurgie. Cancer 1996;77:1254-1262.
23. Malik HZ, Prasad R, Halazum KJ, et al: Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007;246:806-814.
24. Zakaria S, Donohue JH, Que FG, et al: Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 2007;246:183-191.
25. Rees M, Tekkis PP, Welsh FKS, et al: Evaluation of long-tem survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008;247:125-135.
26. McMillan DC, Canna K, McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003;90:215-219.
27. Walsh SR, Cook EJ, Goulder F, et al: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-184.
28. Oakes DA: Concordance test for independence in the presence of censoring. Biometrics 1982;38:451-455.
29. Gurusamy KS, Imber C, Davidson BR: Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg 2008;2008:684150.
30. Hosmer DW, Lemeshow S: Applied Logistic Regression, ed 2. New York, Wiley, 2000.
31. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
32. Chung KY, Saltz LB: Antibody-based therapies for colorectal cancer. Oncologist 2005;10:701-709.
33. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.